ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI scans old chest X-Rays to flag hidden heart risk
Disease control Not yet recruitingThis large study will test if using artificial intelligence (AI) to check old chest CT scans for calcium buildup in heart arteries can help people get better cholesterol treatment. It will involve about 120,000 adults who have either known heart disease or significant calcium bui…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Nurses go digital to fight heart disease from afar
Disease control Not yet recruitingThis study is testing a new digital care program where nurses remotely help patients manage their heart health. Participants with high blood pressure or cholesterol will use home devices to track their numbers, and nurses will provide guidance. The goal is to see if this approach…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug trial targets dual threat: clogged arteries and ED
Disease control Not yet recruitingThis study is testing an investigational drug called YN001 in men who have both plaque buildup in their arteries (atherosclerosis) and erectile dysfunction. The goal is to see if YN001 can improve blood vessel health and sexual function. About 40 participants will be randomly ass…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC